Pertaining to recent findings, a protein primarily associated with Parkinson’s disease might illuminate why females account for approximately two-thirds of Alzheimer’s cases. The study’s outcomes are featured in the journal JAMA Network Open.
Researchers from the Mayo Clinic in the United States examined a cohort comprising 415 individuals, incorporating those with unimpaired cognitive function as well as those experiencing mild cognitive impairment or dementia, with the objective of identifying disease biomarkers.
In subjects presenting with atypical levels of alpha-synuclein in their cerebrospinal fluid, alongside evidence of Alzheimer’s-related cerebral changes as seen on PET scans, these alterations advanced twenty times more rapidly in women than in men.
Specifically, the brain modifications quantified here involved the detrimental accumulation of the tau protein, a hallmark of brain damage associated with Alzheimer’s and other neurological disorders. Women exhibiting aberrant alpha-synuclein demonstrated the swiftest rate of tau elevation over time, suggesting potential underlying biological distinctions.
These discovered results imply that misfolded alpha-synuclein could function as a catalyst for Alzheimer’s progression in certain scenarios, potentially aiding investigators in formulating more targeted clinical trials and therapeutic approaches down the line.
“When we observe disease-related changes manifesting at dramatically dissimilar velocities, we can no longer approach Alzheimer’s disease as if its course were uniform across everyone,” states neuro-radiologist Kajal Kantarci. “Co-occurring pathologies likely influence the disease trajectory.”
Both alpha-synuclein and tau proteins are naturally produced and serve crucial roles in maintaining neural health. Issues arise when they begin to malfunction and spiral out of control, although whether they initiate the diseases or are consequences remains unclear.
About half of Alzheimer’s patients exhibit abnormal, misfolded alpha-synuclein proteins in their brains, even though this issue is far more pronounced in Parkinson’s disease and related dementias, where it is considered a primary driver.
The investigators controlled for several variables, including age and genetic predisposition, when charting the association between these two proteins, though other currently unexamined factors may also be at play.
The confirmation that the link between misfolded alpha-synuclein and accelerated increases in the detrimental tau protein was exclusive to females suggests that biological mechanisms are occurring that are not apparent in males, and deciphering these processes could advance our comprehension of Alzheimer’s.
“This opens an entirely new avenue for understanding why women bear a disproportionate burden of dementia,” comments neuroscientist Elijah Mak.
The research team harbors some initial ideas regarding the drivers of this disparity, although these notions warrant further scrutiny. A more pronounced and abrupt decline in estrogen levels among women at later ages could be a contributing element, as estrogen might offer a protective shield against the buildup of toxic proteins.
Another working theory posits that malfunctioning alpha-synuclein proteins behave as a “second-hit amplifier,” exacerbating brain inflammation and worsening the aggregation of tau.
This study does not establish a definitive cause-and-effect relationship between issues with alpha-synuclein and tau, and the mean follow-up period was relatively brief—just over a year. More longitudinal investigations are needed to map out completely how alterations in these proteins affect Alzheimer’s development over extended periods.
Nevertheless, every new piece of evidence assists investigators in building a clearer picture of how Alzheimer’s disease might commence and why specific demographic groups, including women, face an elevated vulnerability to developing the condition.
The research group also suggests their findings might prove valuable in diagnosing Alzheimer’s, Parkinson’s, and associated dementias, offering assistance in differentiating between overlapping conditions that can sometimes obscure one another.
About the Author
